Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$148.43 1.60 (1.07%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.26(B)
Last Volume: 1,250,341 Avg Vol: 722,222
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 76,855 102,504 247,093
Total Sell Value $0 $12,957,715 $17,713,340 $48,829,179
Total People Sold 0 7 8 9
Total Sell Transactions 0 12 18 35
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 748
  Page 21 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-12-17 4 AS $60.59 $1,127,761 D/D (18,480) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-12-17 4 OE $12.96 $239,501 D/D 18,480 31,068     -
   Greene Barry E President and COO   •       –      –    2013-12-17 4 OE $6.78 $75,936 D/D 11,200 15,772     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-12-16 4 AS $60.20 $482,872 D/D (8,000) 7,847     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-12-16 4 OE $9.14 $100,510 D/D 8,000 15,847     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-12-16 4 AS $60.19 $905,298 D/D (15,000) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-12-16 4 OE $7.10 $127,900 D/D 15,000 27,588     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-12-02 4 AS $61.55 $231,863 D/D (3,750) 7,847     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2013-12-02 4 OE $7.10 $26,625 D/D 3,750 11,597     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2013-11-13 4 AS $53.36 $720,302 D/D (13,500) 11,681     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2013-11-13 4 OE $15.99 $215,865 D/D 13,500 25,181     -
   Schimmel Paul Director   –       •      –    2013-10-22 4 AS $60.00 $900,000 D/D (15,000) 126,216     -
   Schimmel Paul Director   –       •      –    2013-10-22 4 OE $9.30 $139,500 D/D 15,000 141,216     -
   Maraganore John Chief Executive Officer   •       •      –    2013-10-10 4 OE $6.78 $85,869 D/D 12,665 31,282     -
   Maraganore John Chief Executive Officer   •       •      –    2013-09-11 4 AS $55.41 $3,271,524 D/D (58,947) 18,617     -
   Maraganore John Chief Executive Officer   •       •      –    2013-09-11 4 OE $0.95 $56,000 D/D 58,947 77,564     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-09-10 4 AS $57.39 $359,238 D/D (6,250) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2013-09-10 4 OE $9.30 $58,125 D/D 6,250 18,838     -
   Maraganore John Chief Executive Officer   •       •      –    2013-08-14 4 AS $48.77 $2,938,127 D/D (60,000) 18,617     -
   Maraganore John Chief Executive Officer   •       •      –    2013-08-14 4 OE $0.95 $57,000 D/D 60,000 78,617     -
   Mason Michael VP, Finance & Treasurer   •       –      –    2013-07-12 4 AS $50.00 $710,000 D/D (14,200) 7,847     -
   Mason Michael VP, Finance & Treasurer   •       –      –    2013-07-12 4 OE $31.39 $445,738 D/D 14,200 22,047     -
   Maraganore John Chief Executive Officer   •       •      –    2013-07-10 4 AS $37.11 $2,226,822 D/D (60,000) 18,617     -
   Maraganore John Chief Executive Officer   •       •      –    2013-07-10 4 OE $0.95 $57,000 D/D 60,000 78,617     -
   Sharp Philip A Director   –       •      –    2013-07-02 4 D $0.00 $0 I/I (38,837) 213,793     -
  748 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 21 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us